RhumbLine Advisers’s Fibrocell Science Inc. FCSC Stock Holding History

RhumbLine Advisers’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,586	Closed	-$59K	–	3047
2016 Q1	$59K	Hold	1,586	–	–	﹤0.01%	2954
2015 Q4	$108K	Buy	1,586 +168	+12%	+$12.1K	﹤0.01%	2941
2015 Q3	$82K	Buy	1,418 +58	+4%	+$5.13K	﹤0.01%	2961
2015 Q2	$108K	Buy	+1,360	New	+$91.5K	﹤0.01%	2996
2014 Q2	–	Sell	-1,124	Closed	-$88K	–	3099
2014 Q1	$88K	Sell	1,124 -39	-3%	-$3.02K	﹤0.01%	2934
2013 Q4	$71K	Buy	1,163 +180	+18%	+$10.5K	﹤0.01%	2985
2013 Q3	$65K	Sell	983 -11	-1%	-$889	﹤0.01%	2960
2013 Q2	$91K	Buy	+994	New	+$82.2K	﹤0.01%	3256

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RhumbLine Advisers's FCSC Position: Q2 2016 in Review

RhumbLine Advisers sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 1,586 shares — an estimated $59K sold.

RhumbLine Advisers first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $108K in Q4 2015. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

RhumbLine Advisers reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
RhumbLine Advisers sold 1,586 Fibrocell Science Inc. shares in Q2 2016, an estimated $59K.
RhumbLine Advisers first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
RhumbLine Advisers's Fibrocell Science Inc. position peaked at $108K in Q4 2015.
44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.